1 Story in coverage 0 Programs 0 Registered trials DEF 14A Aug 21 Latest SEC filing, period to Sep 30 Aug 11 Latest story
Timeline 1 Pipeline 0 Trials 0
Details
Headquarters Redwood City, CA Incorporated Delaware Industry Pharmaceutical Preparations Formerly Bolt Therapeutics, Inc. (to 2015) Also known as BOLT, Bolt Therapeutics, Inc. How the company describes itself Bolt Biotherapeutics develops Boltbody ISAC, a platform combining tumor-targeting antibodies with immune stimulants to activate myeloid cells against cancer. The approach aims to generate anti-tumor immune responses through recruitment and activation of immune cells in the tumor microenvironment. source
